Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroders Capital Global Innovation Trust Regulatory News (INOV)

Share Price Information for Schroders Capital Global Innovation Trust (INOV)

Share Price is delayed by 15 minutes
Get Live Data
16.85    0.05 (0.30%)
Bid:
16.85
Ask:
17.45
Spread: 0.60 (3.561%)
Market Cap: £107.06m
INOV Live PriceLast checked at - London Stock Exchange

Intraday Schroders Capital Global Innovation Trust Share Chart

Result of AGM

2 Jun 2026 16:12

RNS Number : 7138G
Schroders Capital Gbl Inn Tst PLC
02 June 2026
 

2 June 2026

Schroders Capital Global Innovation Trust plc

(the "Company")

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held earlier today, a poll was held on each of the resolutions proposed in the Notice of Annual General Meeting and each resolution was duly passed.

 

The full text of the resolutions is contained in the Notice of Annual General Meeting in the Company's Annual Report for the year ended 31 December 2025, available on the Company's web pages at www.schroders.com/inov

 

The results of the poll were as follows:

 

 

Resolution

Votes for (including discretionary)

%

Votes against

%

Votes total

% of ISC

Votes withheld

 

Ordinary business

1

To receive the Annual Report & Financial Statements

167,640,876

99.42

973,686

0.58

168,614,562

26.54%

743,109

2

To approve the Remuneration Report

159,771,455

94.88

8,629,754

5.12

168,401,209

26.50%

956,462

3

To re-elect Tim Edwards

158,257,009

93.89

10,303,092

6.11

168,560,101

26.53%

797,570

4

To re-elect Stephen Cohen

157,138,124

93.22

11,428,525

6.78

168,566,649

26.53%

791,022

5

To re-elect Jane Tufnell

157,120,862

93.19

11,475,046

6.81

168,595,908

26.54%

761,763

6

To re-appoint Ernst & Young LLP as Auditor

165,018,176

97.87

3,585,535

2.13

168,603,711

26.54%

753,960

7

To approve the Auditor's remuneration

165,079,709

97.95

3,454,809

2.05

168,534,518

26.53%

823,153

Special business

8

To renew the authority to allot shares

162,945,529

96.58

5,772,056

3.42

168,717,585

26.55%

640,086

9*

To approve the disapplication of pre-emption rights

160,082,966

94.91

8,580,123

5.09

168,663,089

26.55%

694,582

10*

To renew the authority to purchase own shares

167,862,890

99.46

908,963

0.54

168,771,853

26.56%

585,818

11*

To allow the Company to hold general meetings

on a minimum notice period of

14 clear days

163,727,567

97.04

4,988,504

2.96

168,716,071

26.55%

641,600

 

*Resolutions 9, 10, and 11 were passed as special resolutions.

 

A copy of the resolutions passed, other than resolutions concerning ordinary business, at today's AGM will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

Shareholders are entitled to one vote per share. Votes withheld are not a vote in law and are therefore not counted in the calculation of the percentages of the votes cast for and against a resolution. Where shareholders appointed the Chair as their proxy with discretion as to voting, their votes were cast in favour of the resolutions and their shares have been included in the "votes for" column.

 

The total number of ordinary shares of 1p each in issue and eligible to vote at the meeting was 635,361,925. The total number of voting rights is 635,361,925. The Company holds no shares in treasury.

 

Enquiries:

 

Francesca Davis

Schroder Investment Management Limited

020 7658 6000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUURVRNKUNRAR
Date   Source Headline
23rd Feb 202410:37 amRNSNet Asset Value(s)
22nd Feb 202410:55 amRNSNet Asset Value(s)
21st Feb 20244:52 pmRNSTransaction in Own Shares
21st Feb 202410:29 amRNSNet Asset Value(s)
20th Feb 20243:54 pmRNSTransaction in Own Shares
20th Feb 202410:28 amRNSNet Asset Value(s)
19th Feb 20245:40 pmRNSTransaction in Own Shares
19th Feb 202410:41 amRNSNet Asset Value(s)
16th Feb 20244:35 pmRNSTransaction in Own Shares
16th Feb 202410:38 amRNSNet Asset Value(s)
15th Feb 20244:55 pmRNSTransaction in Own Shares
15th Feb 202410:53 amRNSNet Asset Value(s)
14th Feb 20244:10 pmRNSTransaction in Own Shares
14th Feb 202410:46 amRNSNet Asset Value(s)
13th Feb 20245:26 pmRNSTransaction in Own Shares
13th Feb 202412:49 pmRNSNet Asset Value(s)
13th Feb 20247:00 amRNSCarmot Therapeutics distribution
9th Feb 20244:11 pmRNSTransaction in Own Shares
9th Feb 202410:21 amRNSNet Asset Value(s)
9th Feb 20247:00 amRNSInvestment in Neurona Therapeutics
8th Feb 20244:10 pmRNSTransaction in Own Shares
8th Feb 202410:51 amRNSNet Asset Value(s)
7th Feb 202410:20 amRNSNet Asset Value(s)
6th Feb 20244:44 pmRNSTransaction in Own Shares
6th Feb 202410:25 amRNSNet Asset Value(s)
5th Feb 20243:52 pmRNSTransaction in Own Shares
5th Feb 202410:35 amRNSNet Asset Value(s)
5th Feb 20247:00 amRNSKymab milestone payment
2nd Feb 20244:34 pmRNSTransaction in Own Shares
2nd Feb 202410:45 amRNSNet Asset Value(s)
1st Feb 20244:47 pmRNSTransaction in Own Shares
1st Feb 202410:45 amRNSNet Asset Value(s)
31st Jan 20244:57 pmRNSTotal Voting Rights
31st Jan 20244:07 pmRNSTransaction in Own Shares
31st Jan 202410:23 amRNSNet Asset Value(s)
30th Jan 20245:11 pmRNSTransaction in Own Shares
30th Jan 202410:32 amRNSNet Asset Value(s)
29th Jan 20244:30 pmRNSTransaction in Own Shares
29th Jan 202411:18 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 202410:31 amRNSNet Asset Value(s)
25th Jan 202411:01 amRNSNet Asset Value(s)
24th Jan 20245:09 pmRNSTransaction in Own Shares
24th Jan 202410:30 amRNSNet Asset Value(s)
23rd Jan 20245:15 pmRNSTransaction in Own Shares
23rd Jan 202411:13 amRNSNet Asset Value(s)
22nd Jan 20245:01 pmRNSTransaction in Own Shares
22nd Jan 202410:42 amRNSNet Asset Value(s)
19th Jan 20244:17 pmRNSTransaction in Own Shares
19th Jan 202410:17 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.